Researchers published a validated methodology that enables whole‑genome sequencing (WGS) from formalin‑fixed paraffin‑embedded (FFPE) tumor specimens, overcoming historical technical challenges tied to DNA damage and fragmentation. The protocol yields reproducible genomic coverage and variant detection from routine pathology samples, potentially expanding access to comprehensive genomic profiling for precision oncology and biomarker‑driven trial enrollment without requiring fresh frozen tissue.